Platelet-rich fibrin gel for diabetic foot ulcers
Treatments studied
Part of Heart & circulation, Hormones & metabolism, Immune system & allergy, Skin clinical trials.
This trial tests a special gel made from your own blood (platelet-rich fibrin, or PRF) to help heal diabetic foot ulcers that are not getting better with standard care. It may be an option if you have a mild-to-moderate ulcer on the bottom of your foot with good blood flow and no infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have type 1 or type 2 diabetes.
- Your foot ulcer is on the bottom of your foot, below the ankle, not between the toes, and it's been there for at least 30 days.
- The ulcer is between the size of a dime and a small apple (1 to 12 square centimeters), and less than about a quarter-inch deep, with no exposed bone or tendon.
- There is no active infection in the wound, and you have good blood flow to your foot (checked with a simple test).
- You are willing to wear a special boot to keep pressure off the ulcer and follow up for about 14 days of standard care before starting the study treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether stem cells taken from fat tissue (after a small procedure) can help heal a long-lasting diabetic foot ulcer. It mainly aims to help ulcers that are limited to soft tissue and have good blood flow to the foot.
This study tests a special wound dressing made from a placental tissue (called PpLHACM) plus standard care, compared to standard care alone, to help heal diabetic foot ulcers that have not healed with usual treatment. It is for people with diabetes who have a moderate-sized foot ulcer without infection or exposed bone.
This study tests whether a special placental tissue graft placed on a diabetic foot ulcer helps it heal faster than standard wound care alone. It is for people with a diabetic foot ulcer that has not healed after 4 weeks of usual care.
This study tests a new wound therapy for diabetic foot ulcers that haven't healed with standard care. It aims to see if the therapy helps these ulcers heal better and faster.
This Phase 3 trial tests ENERGI-F703 gel to help heal diabetic foot ulcers that have not improved for at least 4 weeks. It may help some people whose wounds meet specific size and non-infection criteria.
This trial tests whether adding a special treatment (cellular acellular and matrix-like products) to standard wound care helps diabetic foot ulcers and venous leg ulcers heal faster. It may be an option if you have a diabetes-related foot ulcer that hasn't healed with standard care.
Hear when a new Diabetic Foot Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.